Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.11 USD
−54.13 M USD
24.38 M USD
25.05 M
About Elutia, Inc.
Sector
Industry
CEO
Charles Randal Mills
Website
Headquarters
Silver Spring
Founded
2015
FIGI
BBG00BRBB838
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women’s Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women’s Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ELUT is 2.92 USD — it has decreased by −9.88% in the past 24 hours. Watch Elutia, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Elutia, Inc. stocks are traded under the ticker ELUT.
ELUT stock has fallen by −11.78% compared to the previous week, the month change is a 3.18% rise, over the last year Elutia, Inc. has showed a −12.84% decrease.
We've gathered analysts' opinions on Elutia, Inc. future price: according to them, ELUT price has a max estimate of 10.00 USD and a min estimate of 8.00 USD. Watch ELUT chart and read a more detailed Elutia, Inc. stock forecast: see what analysts think of Elutia, Inc. and suggest that you do with its stocks.
ELUT reached its all-time high on Jan 27, 2021 with the price of 18.20 USD, and its all-time low was 1.10 USD and was reached on Mar 22, 2023. View more price dynamics on ELUT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ELUT stock is 10.96% volatile and has beta coefficient of 1.48. Track Elutia, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elutia, Inc. there?
Today Elutia, Inc. has the market capitalization of 132.41 M, it has increased by 17.65% over the last week.
Yes, you can track Elutia, Inc. financials in yearly and quarterly reports right on TradingView.
Elutia, Inc. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
ELUT earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.25 USD resulting in a −4.00% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about Elutia, Inc. earnings.
Elutia, Inc. revenue for the last quarter amounts to 5.47 M USD, despite the estimated figure of 5.90 M USD. In the next quarter, revenue is expected to reach 6.65 M USD.
ELUT net income for the last quarter is −9.06 M USD, while the quarter before that showed 1.07 M USD of net income which accounts for −949.20% change. Track more Elutia, Inc. financial stats to get the full picture.
No, ELUT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 21, 2025, the company has 51.00 employees. See our rating of the largest employees — is Elutia, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elutia, Inc. EBITDA is −20.83 M USD, and current EBITDA margin is −85.46%. See more stats in Elutia, Inc. financial statements.
Like other stocks, ELUT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elutia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elutia, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elutia, Inc. stock shows the sell signal. See more of Elutia, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.